Van Strum & Towne Inc. Decreases Position in Procter & Gamble Company (The) $PG

Van Strum & Towne Inc. decreased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 0.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,171 shares of the company’s stock after selling 339 shares during the quarter. Procter & Gamble makes up approximately 2.6% of Van Strum & Towne Inc.’s portfolio, making the stock its 11th biggest position. Van Strum & Towne Inc.’s holdings in Procter & Gamble were worth $8,312,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Stableford Capital II LLC increased its position in Procter & Gamble by 1.1% during the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock worth $993,000 after buying an additional 61 shares during the period. Bernard Wealth Management Corp. increased its position in Procter & Gamble by 20.2% during the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company’s stock worth $64,000 after buying an additional 63 shares during the period. B & T Capital Management DBA Alpha Capital Management increased its position in Procter & Gamble by 2.3% during the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock worth $476,000 after buying an additional 63 shares during the period. Private Management Group Inc. increased its position in Procter & Gamble by 4.8% during the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock worth $236,000 after buying an additional 64 shares during the period. Finally, Lantz Financial LLC increased its position in Procter & Gamble by 1.2% during the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock worth $834,000 after buying an additional 64 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 0.6%

Shares of PG stock opened at $149.69 on Friday. The business’s fifty day moving average price is $155.24 and its 200 day moving average price is $159.48. Procter & Gamble Company has a 1-year low of $149.45 and a 1-year high of $180.43. The firm has a market capitalization of $350.34 billion, a PE ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the company posted $1.40 earnings per share. Procter & Gamble’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PG has been the topic of several research analyst reports. Barclays cut their price target on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Evercore ISI reissued an “in-line” rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Bank of America dropped their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a report on Wednesday. UBS Group dropped their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. dropped their target price on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a report on Friday. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $172.21.

Insider Activity

In related news, insider Marc S. Pritchard sold 9,849 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider owned 182,422 shares of the company’s stock, valued at $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Andre Schulten sold 11,638 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the sale, the chief financial officer owned 52,642 shares in the company, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock valued at $23,421,279 over the last three months. 0.20% of the stock is currently owned by corporate insiders.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.